Therapeutic Class
Lilly working ‘around the clock’ to ensure Mounjaro supply
Facilities & CapacityLilly working ‘around the clock’ to ensure Mounjaro supplyLilly working ‘around the clock’ to ensure Mounjaro supply
Four manufacturing plants are in the works to support the rollout of Eli Lilly’s type 2 diabetes GLP-1 receptor Mounjaro (tirzepatide).